Published in Ophthalmologe on June 01, 2010
Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers. Graefes Arch Clin Exp Ophthalmol (2014) 0.95
[Operative techniques for surgical treatment of primary and recurrent pterygia]. Ophthalmologe (2010) 0.80
Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study. J Ocul Biol Dis Infor (2013) 0.77
Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology (1992) 6.62
The treatment of pterygium. Surv Ophthalmol (2003) 3.97
The effect of topical bevacizumab on corneal neovascularization. Ophthalmology (2008) 2.26
Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol (1984) 2.06
Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol (2007) 1.82
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology (2009) 1.67
Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res (2004) 1.66
The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf (2008) 1.41
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Bevacizumab application delays epithelial healing in rabbit cornea. Invest Ophthalmol Vis Sci (2009) 1.14
Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr Eye Res (2008) 1.11
Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol (2009) 1.09
Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci (2009) 1.02
Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea (2009) 1.00
Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology (2005) 0.91
Topical cyclosporin A and mitomycin C injection as adjunctive therapy for prevention of primary pterygium recurrence. Ophthalmic Surg Lasers Imaging (2009) 0.91
[Antiangiogenic therapy for pterygium recurrence]. Ophthalmologe (2009) 0.88
Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence. Cornea (2008) 0.88
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy]. Ophthalmologe (2009) 0.87
Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol (2002) 0.81
Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study. Am J Ophthalmol (1998) 0.81
[Amniotic membrane transplantation for reconstruction of the ocular surface]. Ophthalmologe (2001) 0.80
Prospective study on the safety and efficacy of combined conjunctival rotational autograft with intraoperative 0.02% mitomycin C in primary pterygium excision. Cornea (2009) 0.80
Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlenther Onkol (2009) 0.79
Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients. Cornea (2008) 0.79
[Effect of pterygium operation on preoperative astigmatism. Prospective study]. Ophthalmologe (1993) 0.78
[Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva]. Ophthalmologe (2009) 0.75
Pterygium/pinguecula and the five-year incidence of age-related maculopathy. Am J Ophthalmol (2005) 0.75
Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res (2008) 1.85
Silicone oil-associated optic nerve degeneration. Am J Ophthalmol (2001) 1.44
[Immune reactions after DMEK, DSAEK and DALK]. Klin Monbl Augenheilkd (2013) 1.34
[Current aspects of eyelid, lacrimal and orbital surgery in childhood]. Ophthalmologe (2015) 1.32
[Differential eyelid tumor diagnosis. I]. Ophthalmologe (2002) 1.16
[Corneal crosslinking: "Safe and effective"?]. Ophthalmologe (2009) 1.10
Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol (2009) 0.96
Orbital involvement in cherubism. Ophthalmology (2001) 0.95
[Inhibition of angiogenesis in the anterior chamber of the eye]. Ophthalmologe (2007) 0.94
[Conservative and surgical treatment of neurotrophic keratopathy]. Ophthalmologe (2005) 0.93
[Classification of ocular surface disease. Part 1]. Ophthalmologe (2003) 0.92
Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: clinical and neuropathological observations in a 33-year-old man. Am J Med Genet (1998) 0.91
Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp Eye Res (2008) 0.89
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy]. Ophthalmologe (2009) 0.87
Primary intraosseous cavernous hemangioma of the orbit. Am J Ophthalmol (2001) 0.87
Surgery of the cornea: corneal, limbal stem cell and amniotic membrane transplantation. Dev Ophthalmol (2008) 0.87
Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty. Arch Ophthalmol (1999) 0.86
[Synopsis of various electrophysiological tests in early glaucoma diagnosis--temporal and spatiotemporal contrast sensitivity, light- and color-contrast pattern-reversal electroretinogram, blue-yellow VEP]. Klin Monbl Augenheilkd (2000) 0.85
[DALK and penetrating laser keratoplasty for advanced keratoconus]. Ophthalmologe (2013) 0.84
[Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty]. Klin Monbl Augenheilkd (2004) 0.84
[Transitory intrathoracic and -abdominal pressure elevation in the history of 64 patients with normal pressure glaucoma]. Klin Monbl Augenheilkd (2001) 0.84
[Anti-inflammatory treatment in dry eye disease]. Klin Monbl Augenheilkd (2012) 0.83
[Research activities of medical students in Germany using as an example the Würzburg University Clinic]. Dtsch Med Wochenschr (1998) 0.83
[Patient satisfaction after posterior lamellar keratoplasty (DSAEK)]. Klin Monbl Augenheilkd (2008) 0.82
Breast carcinoma metastatic to the eyelid presenting as the first sign of insufficient chemotherapy. Ophthalmologica (2001) 0.82
[Immunological graft reactions after penetrating keratoplasty - A prospective randomized trial comparing corneal excimer laser and motor trephination]. Klin Monbl Augenheilkd (2001) 0.82
[The dry eye. Current concepts on classification, diagnostics, and pathogenesis]. Ophthalmologe (2006) 0.82
Changes in donor corneal lenticule thickness after Descemet's stripping automated endothelial keratoplasty (DSAEK) with organ-cultured corneas. Br J Ophthalmol (2009) 0.81
[Complications after posterior lamellar keratoplasty (DSAEK): prevention, detection and treatment]. Klin Monbl Augenheilkd (2010) 0.81
[Significance of transcanalicular laser assisted dacryocystorhinostomy in modern lacrimal drainage surgery]. Ophthalmologe (2015) 0.81
[Pediatric corneal surgery and corneal transplantation]. Ophthalmologe (2015) 0.80
[Operative techniques for surgical treatment of primary and recurrent pterygia]. Ophthalmologe (2010) 0.80
Blood-aqueous barrier breakdown after penetrating keratoplasty with simultaneous extracapsular cataract extraction and posterior chamber lens implantation. Graefes Arch Clin Exp Ophthalmol (2001) 0.79
[Split-cornea transplantation - a novel concept to reduce corneal donor shortage]. Klin Monbl Augenheilkd (2012) 0.79
[Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department]. Ophthalmologe (2008) 0.78
[Long-term outcome after penetrating keratoplasty for bullous keratopathy - influence of preoperative visual acuity on final outcome]. Klin Monbl Augenheilkd (2011) 0.78
[Pseudotumor of the cornea in childhood]. Ophthalmologe (2014) 0.78
[Long-term outcome after penetrating keratoplasty for keratoconus--impact of preoperative corneal curvature and best corrected visual acuity on the functional results]. Klin Monbl Augenheilkd (2010) 0.78
[Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca]. Klin Monbl Augenheilkd (2011) 0.78
[Epiphora with pressure-indolent swelling of the medial canthus]. Ophthalmologe (2014) 0.78
[Inflammation of the eye in systemic inflammatory disorders: keratitis]. Klin Monbl Augenheilkd (2011) 0.78
[Screening questionnaire for documentation of medical history and diagnostic findings in dry eye disease]. Klin Monbl Augenheilkd (2010) 0.77
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol (2009) 0.77
[Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment]. Ophthalmologe (2008) 0.77
[Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea® and KeraKlear®]. Ophthalmologe (2014) 0.77
[Histopathology of retrocorneal membranes after keratoplasty]. Klin Monbl Augenheilkd (2010) 0.77
[Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)]. Ophthalmologe (2014) 0.77
[Endothelial immune reactions in times of lamellar corneal transplant surgery: mission completed?]. Klin Monbl Augenheilkd (2013) 0.76
[Antiangiogenic therapy at the ocular surface: when, what and why?]. Ophthalmologe (2011) 0.76
[Ophthalmological complications in Sjögren's syndrome]. Z Rheumatol (2010) 0.76
[Late complications after chemical burns of the ocular surface. Surgical strategies for ocular surface reconstruction]. Ophthalmologe (2011) 0.76
[Visual rehabilitation and intraocular pressure elevation due to immunological graft rejection following penetrating keratoplasty]. Klin Monbl Augenheilkd (2001) 0.75
Two-step retrograde closed stenting: a novel method for treating canalicular lacerations in Chinese patients. Eye (Lond) (2013) 0.75
Amniotic membrane-covered bio-onlays for treatment of ocular surface disease. Br J Ophthalmol (2007) 0.75
Regression of mature lymphatic vessels in the cornea by photodynamic therapy. Br J Ophthalmol (2014) 0.75
[Retained Descemet's membrane after penetrating keratoplasty for macular corneal dystrophy]. Ophthalmologe (2010) 0.75
[Glaucoma and dry eye. Current concepts and future perspectives]. Ophthalmologe (2013) 0.75
[Special topic: inflammations of the ocular surface]. Klin Monbl Augenheilkd (2012) 0.75
[Ophthalmological manifestations of Cornelia de Lange syndrome: Case report and review of the literature]. Ophthalmologe (2015) 0.75
"OSMO-UT-DSAEK" using THIN-C medium. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
[Special focus: inflammatory diseases of the eye]. Klin Monbl Augenheilkd (2014) 0.75
[Special topic "inflammations of the eye in inflammatory systemic diseases"]. Klin Monbl Augenheilkd (2011) 0.75
Optic neuropathy resembling normal-pressure glaucoma in a teenager with congenital macrodiscs. Arch Ophthalmol (1998) 0.75
[Conjunctival chemosis resistant to therapy]. Klin Monbl Augenheilkd (2006) 0.75
[Rare but important Disease: Update on ocular GvHD]. Klin Monbl Augenheilkd (2015) 0.75
[In Process Citation]. Ophthalmologe (2015) 0.75
[Morbus Morbihan : A rare cause of edematous swelling of the eyelids]. Ophthalmologe (2010) 0.75
Biomolecular markers of malignancy in human uveal melanoma: the role of the cadherin-catenin complex and gene expression profiling. Ophthalmologica (2003) 0.75
[Pseudo-tumor of the iris following cataract surgery]. Ophthalmologe (2013) 0.75
[In Process Citation]. Ophthalmologe (2015) 0.75